Acute renal failure in cystic fibrosis

October 2007
Archives of Disease in Childhood;Oct2007, Vol. 92 Issue 10, p915
Academic Journal
The article offers information on the study conducted by the Great Britain cystic fibrosis centers on acute renal failure in patients with cystic fibrosis. The study assesses about 55 possible cases of acute renal failure between 1997 and 2004. This study estimated that the incidence was 4.6-10.5 cases of acute renal failure per 10,000 cases of cystic fibrosis in the country per year. In 21 cases an aminoglycoside antibiotic was medicated before the onset of acute renal failure. Moreover, acute renal failure in patients with cystic fibrosis were found related to the use of an aminoglycoside.


Related Articles

  • Aminoglycosides linked to acute renal failure in CF patients.  // Reactions Weekly;8/11/2007, Issue 1164, p3 

    The article discusses the results of a survey of acute renal failure (ARF) in patients with cystic fibrosis (CF) in Great Britain. The survey found that ARF in patients with CF implicate IV aminoglycosides as an etiological factor. Based on responses, 55 cases were identified with consent given...

  • In vitro modulation of tubular cyst regression in murine polycystic kidney disease. Avner, Ellis D.; Sweeney, Jr., William E.; Ellis, Demetrius // Kidney International;Dec1989, Vol. 36 Issue 6, p960 

    Recent studies in a murine model of genetically-determined polycystic kidney disease, the CPK mouse, have suggested that alterations in renal Na-K ATPase activity in concert with tubular epithelial hyperplasia have pathogenic import in proximal tubular cysi formation. In the current study, we...

  • Should we stop using intravenous gentamicin in patients with cystic fibrosis? Goss, Christopher H. // Thorax;Jun2008, Vol. 63 Issue 6, p479 

    The article discusses various reports published within the issue including one by A. Smith on the case-control study of acute renal failure in patients with cystic fibrosis and another by M. Al-Aloul on renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

  • Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin. Bockenhauer, Detlef; Hug, Martin J.; Kleta, Robert // Pediatric Nephrology;May2009, Vol. 24 Issue 5, p925 

    Aminoglycosides have a wide spectrum of gram-negative anti-bacterial activities and are available at low cost, which makes them commonly used drugs, especially for patients with cystic fibrosis (CF), who often suffer from chronic lung infections from Pseudomonas aeruginosa. Unfortunately, this...

  • Características funcionais pulmonares e uso de broncodilatador em pacientes com fibrose cística. Muramatu, Lucia Harumi; Stirbulov, Roberto; Neves Forte, Wilma Carvalho // Jornal Brasileiro de Pneumologia;ene/feb2013, Vol. 39 Issue 1, p48 

    Objective: To analyze pulmonary function parameters and pharmacodynamic response to a bronchodilator, as well as the prescription of bronchodilators, in cystic fibrosis (CF) patients. Methods: This was a retrospective cohort study involving patients 6-18 years of age, diagnosed with CF, and...

  • Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis. Downes, Kevin; Patil, Neha; Rao, Marepalli; Koralkar, Rajesh; Harris, William; Clancy, John; Goldstein, Stuart; Askenazi, David // Pediatric Nephrology;Oct2015, Vol. 30 Issue 10, p1879 

    Background: Aminoglycoside (AG) therapy is a common cause of acute kidney injury (AKI) in cystic fibrosis (CF) patients. The aim of this study was to identify factors associated with AKI during intravenous AG courses in this population. Methods: This was a matched case-control study utilizing...

  • An overview of the management of cystic fibrosis. Littlewood, J. M. // Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p55 

    The article discusses the management of cystic fibrosis (CF). The use sweat for electrolyte analysis is described. Guidelines for establishing a correct diagnosis are listed, including the administration of two positive sweat tests. The availability of antibiotics effective against respiratory...

  • Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. Liat Linde; Boelz, Stephanie; Nissim-Rafinia, Malka; Oren, Yifat S.; Wilschanski, Michael; Yaacov, Yasmin; Virgilis, Dov; Neu-Yilik, Gabriele; Kulozik, Andreas E.; Kerem, Eitan; Kerem, Batsheva // Journal of Clinical Investigation;Mar2007, Vol. 117 Issue 3, p683 

    Aminoglycosides can readthrough premature termination codons (PTCs), permitting translation of full-length proteins. Previously we have found variable efficiency of readthrough in response to the aminoglycoside gentamicin among cystic fibrosis (CF) patients, all carrying the W1282X nonsense...

  • Non-urate transporter 1-related renal hypouricemia and acute renal failure in an Israeli–Arab family. Bahat, Hilla; Dinour, Dganit; Ganon, Liat; Feldman, Leonid; Holtzman, Eli J.; Goldman, Michael // Pediatric Nephrology;May2009, Vol. 24 Issue 5, p999 

    Idiopathic renal hypouricemia (IRHU) is a rare hereditary disease, predisposing the individual to exercise-induced acute renal failure (EIARF) and nephrolithiasis, and it is characterized by increased clearance of renal uric acid. Most of the described patients are Japanese, who have...


Read the Article

Other Topics